StonvexLoading…
StonvexStonvexStonvexCore line items from AXGN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $61.46M | $225.21M | $165.30M | $105.22M |
Operating Income | $-2.83M | $-7.85M | $1.92M | $11.00K |
Net Income | $-19.58M | $-15.70M | $-2.55M | $-3.25M |
EPS (Diluted) | $-0.38 | $-0.34 | $-0.06 | $-0.07 |
Total Assets | $289.49M | $221.69M | $216.40M | $205.45M |
Total Liabilities | $44.68M | $92.84M | $95.59M | $93.18M |
Cash & Equivalents | $82.65M | $35.55M | $23.90M | $20.04M |
Free Cash Flow OCF − CapEx | $-1.22M | $-2.93M | $-4.72M | $-6.43M |
Shares Outstanding | 53.15M | 47.20M | 46.12M | 45.77M |